Skip to main content
. 2019 Autumn;18(4):2180–2190. doi: 10.22037/ijpr.2019.14733.12619

Figure 3.

Figure 3

Pooled mean difference of HbA1c reduction (A) and FSG reduction (B) in patients who received dulaglutide compared to liraglutide